Filing Details
- Accession Number:
- 0001213900-22-033077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-15 16:31:04
- Reporting Period:
- 2022-06-14
- Accepted Time:
- 2022-06-15 16:31:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1797876 | David Bench | C/O Enzo Biochem, Inc. 527 Madison Avenue New York NY 1002 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2022-06-14 | 3,500 | $2.15 | 6,000 | No | 4 | P | Indirect | By Trust (PSP) |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust (PSP) |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.01 Par Value | 4,138 | Indirect | 401k |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (to acquire Common Stock) | $2.98 | 2023-03-24 | 2027-03-24 | 87,500 | 87,500 | Direct |
Common Stock | Stock Option (to acquire Common Stock) | $3.36 | 2023-02-11 | 2027-02-11 | 87,500 | 87,500 | Direct |
Common Stock | Stock Option (to acquire Common Stock) | $2.63 | 2022-01-11 | 2026-01-11 | 55,400 | 55,400 | Direct |
Common Stock | Stock Option (to acquire Common Stock) | $2.20 | 2021-02-24 | 2025-02-24 | 55,400 | 55,400 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-03-24 | 87,500 | 87,500 | Direct |
2027-02-11 | 87,500 | 87,500 | Direct |
2026-01-11 | 55,400 | 55,400 | Direct |
2025-02-24 | 55,400 | 55,400 | Direct |
Footnotes
- Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
- Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
- The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.